RAD stock has nearly tripled in the last two weeksRite Aid Corporation (NYSE:RAD) stock has been ripping higher since the drugstore chain reported a third-quarter revenue beat the morning of Dec. 19, while also lowering its full-year net loss outlook. Since its Dec. 18 close at $8.32, RAD shares are up 157% -- including today's 11.6% pop that has the equity trading at $21.42, pacing toward a seven...Read More
The Nasdaq is in the midst of a 12-day winning streakWall Street had a lot to celebrate during the holiday-shortened week. Although Christmas and Christmas Eve led to lower trading volumes, that didn't stop the Dow, S&P 500, and Nasdaq from nabbing record closes left and right. The tech-heavy Nasdaq in particular broke out, and is currently heading toward its 12th straight win. U.S.-China trade op...Read More
The tech-heavy index is headed for a 12th straight daily winThe Dow Jones Industrial Average (DJI) hit a new high out of the gate today, extending a Christmas week rally that's put the blue-chip index on track for a third straight weekly win. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) also tagged fresh peaks today, with the latter index holding above the round 9,000 mark, and pacing towar...Read More
TSLA has soared 144% since early JuneShares of electric car maker Tesla Inc (NASDAQ:TSLA) nabbed a new record high of $435.31 out of the gate, after revealing it will deliver the first 15 Model 3 cars made in its Shanghai factory on Monday. While the shares have since pared those gains to trade up 0.2% at $431.58, today's lift is just another step in a long-term climb for TSLA. The stock now up...Read More
An exodus of short sellers could push FLXN even higherThe shares of Flexion Therapeutics Inc (NASDAQ:FLXN) are near the top of the Nasdaq this morning, up 10.8% to trade at $21.01, and nabbed a new annual high of $22.98 out of the gate. Powering today's surge is a Food and Drug Administration (FDA) updated label approval of Zilretta, the company's osteoarthritis treatment. At least three brokera...Read More
The FDA just approved the company's fast track application for its breast cancer drug yesterdayImmunomedics, Inc (NASDAQ:IMMU) is climbing towards another annual closing high today, up 2.3% at $22.16, after H.C. Wainwright lifted its price target to $31 from $26. This bull note come right on the heels of yesterday's news that the Food and Drug Administration (FDA) accepted the firm's resubmitted B...Read More
The Santa Claus rally is in full swing this yearFresh off a post-Christmas climb to new record highs, Dow Jones Industrial Average (DJI) futures are signaling a nearly triple-digit pop out of the gate this morning. The S&P 500 Index (SPX) and Nasdaq-100 Index (NDX) are also on pace for positive opens today, with the Santa Claus rally taking a strong hold this year amid trade tailwinds. The latt...Read More
Daniel R. Amerman, CFA On August 27th, 2019, in an editorial published in Bloomberg, William Dudley, the former president of the Federal Reserve Bank Of New York, did what had previously been considered unthinkable. The foundation premise of the Federal Reserve is that it is supposed to be completely nonpartisan, insulated from all political considerations. However, Dudley wrote that Donald Tru...Read More
By: Avi Gilburt Originally published on Sat Dec 21 for members of ElliottWaveTrader.net: When the metals are in a bear market, metals enthusiasts are frustrated. And, even when the metals are in a bull market, metals enthusiast become frustrated. This is what I have been seeing of late, as the metals are consolidating for their next bullish run.But, if you trade metals, you know that t...Read More
Gary TanashianThey say that Festivus is the "anti-Christmas", but in this case we are going to call it the anti-Christmas Eve as the markets close out 2018's Christmas Eve massacre."Many Christmases ago I went to buy a doll for my son. I reached for the last one they had, but so did another man. As I rained blows upon him I realized there had to be another way!"This year markets are going anot...Read More
- Bob MoriartyMy Best Year-End Tax-Loss Harvesting AdviceWith only a few trading days remaining in 2019, a clear winner has emerged in the contest of gold mining ETFs. The U.S. Global GO GOLD and Precious Metal Miners ETF (GOAU) was up 39.5 percent year-to-date as of November 30, beating five of its peers, including those that focus on explorers and junior miners, or that are backed by physi...Read More
Traders will start taking positions for January. January will be the real test for gold and silver bulls. Signing of trade deal, Brexit, various US jobs numbers and Chinese demand and Chinese economic growth around the Chinese New Year. Bonds can also be a surprise winner if gold and silver sell off in January. I am bullish on global stock markets if the trade deal is signed in January. Trade de...Read More
Jesse Ventura and world-renowned astrophysicist Neil deGrasse Tyson talk about the relationship between astrophysics in military conquest, possible space wars, science denialism, and exploring Jupiter's moon Europa. Jesse Ventura, is an American politician, actor, author, Navy Seal, and former professional wrestler who served as the 38th Governor of Minnesota from 1999 to 2003. Ventura remains pol...Read More
"Our aim is not only to relieve the symptom of poverty," he said, "but to cure it, above all, to prevent it."Continue...Read More
"Email from the Chief of Cabinet at the OPCW, demanding deletion of dissenting engineering assessment: "Please get this document out of DRA [Documents Registry Archive]... And please remove all traces, if any, of its Continue...Read More
Well, I've said for years that China is in the process of taking over Africa. In fact, that was a subtheme in my first novel Speculator, about the gold mining Continue...Read More
Bob Thompson of Raymond James in Vancouver joins us to discuss the ongoing rally in precious metals prices as well as his expectations for the mining shares in 2020.Read More
The truth is Bitcoin's a lot like the Internet stocks, insofar as they first bubbled massively, peaked, then crashed. Then out of the ashes began the real longer-term boom from late 2002 Continue...Read More
"You can't say billionaires shouldn't exist and then take maximum contributions from billionaires that the average person can't make."Read More
As Wall Street On Parade has previously reported, JPMorgan Chase has been fingered as the bank that contributed to the Federal Reserve having to Continue...Read More